Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Cohen & Company Inc. (AMEX:COHN) Q1 2023 Earnings Call Transcript

Cohen & Company Inc. (AMEX:COHN) Q1 2023 Earnings Call Transcript May 6, 2023

Operator: Good morning, ladies and gentlemen. Welcome to the Cohen & Company’s First Quarter 2023 Earnings Call. My name is Alicia, and I’ll be your operator for today. Before we begin, Cohen & Company would like to remind everyone that some of the statements the company makes during this call may contain forward-looking statements under applicable security laws. These statements may involve risks and uncertainties that could cause the company’s actual results to differ materially from the results discussed in such forward-looking statements. The forward-looking statements made during this call are made only as of the date of this call, and the company undertakes no obligation to update such statements to reflect subsequent events or circumstances.

Cohen & Company advises you to read the cautionary note regarding forward-looking statements in its earnings release and its most recent annual report on Form 10-K filed with the SEC. I would like now to turn the call over to Mr. Lester Brafman, Chief Executive Officer of Cohen & Company.

Lester Brafman: Thank you, Alicia, and thank you, everyone, for joining us for our first quarter 2023 earnings call. With me on the call is Joe Pooler, our CFO. Our investment portfolio continues to impact our results as our combined negative principal transaction revenue and loss from equity method affiliates amounted to $3 million for the quarter. The prolonged slump in investment banking and origination resulted in less-than-expected new issue and advisory revenues during the quarter. We strongly believe in our team of bankers and originators as we continue to build our pipeline and look forward to more favorable capital markets. As we move forward, we remain focused on enhancing stockholder value. In the first quarter, we continued to pay our quarterly dividend. Now I will turn the call over to Joe to walk through the quarter’s financial highlights in more detail.

Joe Pooler: Thank you, Lester. We’ll start with our statement of operations. Our net loss attributable to Cohen & Company Inc. was $2.6 million for the quarter or $1.77 per fully diluted share compared to net loss of $3 million for the prior quarter or $2.10 per fully diluted share, and net loss of $7.6 million for the prior year quarter or $5.46 per fully diluted share. Our adjusted pretax loss was $9.6 million for the quarter compared to adjusted pretax loss of $6.1 million for the prior quarter and adjusted pretax loss of $18.6 million for the prior-year quarter. Note that adjusted pretax loss is not a measure recognized under U.S. GAAP. See our disclosures, calculations and reconciliations surrounding adjusted pretax loss in our earnings release.

First quarter ’23 principal transactions and other revenue was negative $2.3 million. The negative principal transactions and other revenue was primarily due to mark-to-market adjustments on our principal investments related to our involvement in the SPAC market as a sponsor, asset manager and investor, which has resulted in increased holdings of public equity positions in post-business combination companies. Principal transactions revenue includes all gains and losses and income earned on our $22.4 million investment portfolio classified as other investments at fair value on our balance sheet. Net trading revenue came in at $8.2 million in the first quarter, down $1.4 million from the fourth quarter and $3.8 million from the first quarter of ’22.

The decrease from both of the prior quarters was due primarily to lower trading revenue from our mortgage group. New issue and advisory revenue was $0.9 million in the first quarter, a decrease of $3.3 million from the fourth quarter and $2.9 million from the year ago quarter. Our asset management revenue totaled $2 million in the quarter, which was up $0.3 million from the prior quarter and $0.1 million from the prior year quarter. Compensation and benefits expense for the quarter was $10.5 million, which was up from the prior quarter and down from the prior year quarter, primarily due to fluctuations in revenue and variable incentive compensation. The number of company employees was 121 at the end of March ’23 compared to 121 as of December of ’22 and 115 as of the year ago March.

Net interest expense for the first quarter of ’23 was $1.6 million, including $1.2 million on our 2 trust preferred debt instruments, $111,000 on our senior notes, $65,000 on our credit line and $207,000 on our redeemable financial instrument. Loss from equity method affiliates during the quarter totaled $400,000. During the first quarter, income tax expense was $600,000 compared to $1.3 million in the prior quarter and $1.8 million in the prior year quarter. We will continue to evaluate our operations on a quarterly basis and may make adjustments to our valuation allowances applied against our net operating loss and net capital loss tax assets going forward. In terms of our balance sheet, at the end of the quarter, total equity was $82.4 million compared to $94 million as of the end of 2022.

The nonconvertible noncontrolling interest component of total equity was $153,000 at the end of the quarter and $17,000 at the end of December of ’22. Thus, the total equity, excluding the nonconvertible noncontrolling interest component was $82.2 million at the end of the quarter and $11.8 million decrease from $94 million at the end of 2022. At quarter end, consolidated corporate indebtedness was carried at $29.2 million, and our redeemable financial instruments were carried at $7.9 million. As Lester mentioned, we’ve declared a quarterly dividend of $0.25 per share payable on June 2 of ’23 to stockholders of record as of May 18, of ’23. The Board of Directors will continue to evaluate the dividend policy each quarter and future decisions regarding dividends may be impacted by quarterly operating results and the company’s capital means.

With that, I’ll turn it back over to Lester — or to Alicia to open up the call lines for questions.

Lester Brafman: Thanks, Joe. Please direct any off-line investor questions to Joe Pooler at (215) 701-8952 or via e-mail to investorrelations@cohenandcompany.com. The contact information can also be found at the bottom of our earnings release. Operator, you may now open the call line for questions, and thank you all for joining us today.

Operator:

Lester Brafman: Thank you all for joining us, and we look forward to speaking to you for our next quarter. Operator, you can now close the line.

Operator: This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.

Follow Cohen & Co Inc. (NYSEMKT:COHN)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…